Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement

Author： Kumar Sushil   Mokhtari Reza Bayat   Yeger Herman   Baruchel Sylvain  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.11, 2012-11, pp. : 1093-1106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on mouse brain tumor models in cancer drug discovery

By Hambardzumyan Dolores   Lyustikman Yelena   Holland Eric C  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1435-1451

Informa Healthcare

Access to resources Recommend Favorite

Stent-based drug-delivery systems: current challenges and future trends

By Mani Gopinath  

Therapeutic Delivery, Vol. 4, Iss. 9, 2013-09 ,pp. : 1079-1082

Future Science

Access to resources Recommend Favorite

Ultrasonic Vocalizations as a Measure of Affect in Preclinical Models of Drug Abuse: A Review of Current Findings

By  

Current Neuropharmacology, Vol. 13, Iss. 2, 2015-03 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Drug Discovery for New Anti-Pneumocystis Compounds

By  

Current Medicinal Chemistry, Vol. 16, Iss. 20, 2009-07 ,pp. : 2514-2530

Bentham Science Publishers

Access to resources Recommend Favorite

The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 #946;Gene Product

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 261-267

Bentham Science Publishers

Access to resources Recommend Favorite